可切除非小细胞肺癌的挑战和争议:临床医生的观点
Ilias Houda1, Chris Dickhoff2, Carin A Uyl-de Groot3
1Department of Pulmonary Medicine, Amsterdam UMC, Location VU Medical Center, Cancer Center Amsterdam, de Boelelaan 1117, 1081HV Amsterdam, the Netherlands.
The Lancet regional health. Europe
|March 13, 2024
概括
新的全身治疗方法正在改变早期非小细胞肺癌 (NSCLC) 护理. 这一观点讨论了与这些可切除NSCLC的进步相关的挑战和医疗保健差异.
科学领域:
- 医学瘤学 医学瘤学
- 胸部外科手术 胸部外科手术
- 卫生政策 卫生政策
背景情况:
- 可切除早期非小细胞肺癌 (NSCLC) 的治疗正在迅速发展.
- 欧洲药品署 (EMA) 最近批准了新型辅助剂和新辅助剂全身疗法,这标志着一个重大转变.
- 这些药物包括辅助剂奥西默蒂尼布,辅助剂阿特佐利祖马布,辅助剂布罗利祖马布和新辅助剂尼沃卢马布与化疗.
研究的目的:
- 讨论在可切除早期NSCLC的管理中出现的挑战和争议.
- 突出欧洲国家在获取新疗法方面的潜在不平等.
- 提出解决护理差异的策略.
主要方法:
- 这是一个基于当前临床实践和新兴数据的观点讨论.
- 分析最近的监管批准及其影响.
- 考虑医疗保健系统影响和公平问题.
主要成果:
- 可切除早期NSCLC治疗的景观正在被新的全身疗法重新定义.
- 关于最佳使用和长期结果仍然存在重大问题.
- 医疗保健系统面临着与补偿和可能加剧护理差距相关的挑战.
结论:
- 新型系统性治疗的整合为可切除早期NSCLC提供了有前途的进展.
- 应对医疗保健系统的挑战,并确保欧洲各地的公平获取至关重要.
- 需要进一步的讨论和政策制定,以应对这种转变的治疗模式.
相关概念视频
Ethical Issues
947
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
947
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


